Begin main content

Call for Patient Input: sofosbuvir velpatasvir voxilaprevir

Published on: July 7, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

sofosbuvir velpatasvir voxilaprevir

Brand name Generic name Manufacturer Indication(s)
TBC sofosbuvir velpatasvir voxilaprevir Gilead Sciences Canada, Inc. Hepatitis C, chronic
Project Number Call for patient input Patient input deadline Submit patient input
SF0529-000 2017-07-07 2017-08-28 Submit